Interplay Between MicroRNAs and Oxidative Stress in Ovarian Conditions with a Focus on Ovarian Cancer and Endometriosis

被引:41
作者
Mari-Alexandre, Josep [1 ]
Carcelen, Antonio Pellin [2 ]
Agababyan, Cristina [1 ,3 ]
Moreno-Manuel, Andrea [4 ,5 ]
Garcia-Oms, Javier [1 ,3 ]
Calabuig-Farinas, Silvia [4 ,5 ,6 ,7 ]
Gilabert-Estelles, Juan [1 ,3 ,8 ]
机构
[1] Fdn Hosp Gen Univ Valencia, Res Lab Biomarkers Reprod Gynaecol & Obstet, Valencia 46014, Spain
[2] Univ Valencia, Dept Physiol, Valencia 46010, Spain
[3] Consorcio Hosp Gen Univ Valencia, Comprehens Multidisciplinary Endometriosis Unit, Valencia 46014, Spain
[4] Fdn Invest Hosp Gen Univ Valencia, Mol Oncol Lab, Valencia 46014, Spain
[5] Fdn Invest Hosp Gen Univ Valencia, Ctr Invest Principe Felipe, TRIAL Mixed Unit, Valencia 46014, Spain
[6] Univ Valencia, Dept Pathol, Valencia 46010, Spain
[7] Ctr Invest Biomed Red Canc CIBERONC, Valencia 46014, Spain
[8] Univ Valencia, Dept Paediat Obstet & Gynaecol, Valencia 46010, Spain
关键词
oxidative stress; miRNAs; endometriosis; high-grade serous ovarian cancer; endometriosis-associated ovarian cancer; epithelial-to-mesenchymal transition; chemoresistance; CLEAR-CELL CARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITION; SERUM MICRORNA; INHIBITS PROLIFERATION; CIRCULATING MICRORNAS; EXPRESSION PROFILE; MOLECULAR-CHANGES; PERITONEAL-FLUID; REDOX REGULATION; MIRNA LANDSCAPE;
D O I
10.3390/ijms20215322
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ovarian cancer and endometriosis are two distinct gynaecological conditions that share many biological aspects incuding proliferation, invasion of surrounding tissue, inflammation, inhibition of apoptosis, deregulation of angiogenesis and the ability to spread at a distance. miRNAs are small non-coding RNAs (19-22 nt) that act as post-transcriptional modulators of gene expression and are involved in several of the aforementioned processes. In addition, a growing body of evidence supports the contribution of oxidative stress (OS) to these gynaecological diseases: increased peritoneal OS due to the decomposition of retrograde menstruation blood facilitates both endometriotic lesion development and fallopian tube malignant transformation leading to high-grade serous ovarian cancer (HGSOC). Furthermore, as HGSOC develops, increased OS levels are associated with chemoresistance. Finally, continued bleeding within ovarian endometrioma raises OS levels and contributes to the development of endometriosis-associated ovarian cancer (EAOC). Therefore, this review aims to address the need for a better understanding of the dialogue between miRNAs and oxidative stress in the pathophysiology of ovarian conditions: endometriosis, EAOC and HGSOC.
引用
收藏
页数:24
相关论文
共 167 条
  • [1] miR-196b targets c-myc and Bcl-2 expression, inhibits proliferation and induces apoptosis in endometriotic stromal cells
    Abe, Wakana
    Nasu, Kaei
    Nakada, Chisato
    Kawano, Yukie
    Moriyama, Masatsugu
    Narahara, Hisashi
    [J]. HUMAN REPRODUCTION, 2013, 28 (03) : 750 - 761
  • [2] BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation-Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
    Alsop, Kathryn
    Fereday, Sian
    Meldrum, Cliff
    deFazio, Anna
    Emmanuel, Catherine
    George, Joshy
    Dobrovic, Alexander
    Birrer, Michael J.
    Webb, Penelope M.
    Stewart, Colin
    Friedlander, Michael
    Fox, Stephen
    Bowtell, David
    Mitchell, Gillian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) : 2654 - 2663
  • [3] Abundance of mitochondrial superoxide dismutase is a negative predictive biomarker for endometriosis-associated ovarian cancers
    Amano, Tsukuru
    Chano, Tokuhiro
    Isono, Takahiro
    Kimura, Fuminori
    Kushima, Ryoji
    Murakami, Takashi
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2019, 17 (1)
  • [4] Expression of protease-activated receptor-2 (PAR-2) is related to advanced clinical stage and adverse prognosis in ovarian clear cell carcinoma
    Amen, Murasaki
    Ohishi, Yoshihiro
    Imamura, Hiroko
    Shinozaki, Tomoko
    Yasutake, Nobuko
    Kato, Kiyoko
    Oda, Yoshinao
    [J]. HUMAN PATHOLOGY, 2017, 64 : 156 - 163
  • [5] The Wnt/β-catenin pathway in ovarian cancer: A review
    Arend, Rebecca C.
    Londono-Joshi, Angelina I.
    Straughn, J. Michael, Jr.
    Buchsbaum, Donald J.
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 131 (03) : 772 - 779
  • [6] Vascular morphogenesis in the ovary
    Augustin, HG
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2000, 14 (06) : 867 - 882
  • [7] Evaluation of the cytotoxicity of the Bithionol-paclitaxel combination in a panel of human ovarian cancer cell lines
    Ayyagari, Vijayalakshmi N.
    Diaz-Sylvester, Paula L.
    Hsieh, Tsung-han Jeff
    Brard, Laurent
    [J]. PLOS ONE, 2017, 12 (09):
  • [8] Bithionol inhibits ovarian cancer cell growth In Vitro - studies on mechanism(s) of action
    Ayyagari, Vijayalakshmi N.
    Brard, Laurent
    [J]. BMC CANCER, 2014, 14
  • [9] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [10] Bayani J, 2002, CANCER RES, V62, P3466